<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Department of Medicine</provider_name><provider_url>https://www.med.unc.edu/medicine</provider_url><author_name>Kristen Hendrickson</author_name><author_url>https://www.med.unc.edu/medicine/news/author/berit/</author_url><title>Dr. Patrick Nachman Answers Common Questions about Rituximab Treatment in New Chair's Corner Podcast | Department of Medicine</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="PeRF1DtEy3"&gt;&lt;a href="https://www.med.unc.edu/medicine/news/rituximab-podcast/"&gt;Dr. Patrick Nachman Answers Common Questions about Rituximab Treatment in New Chair&#x2019;s Corner Podcast&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.med.unc.edu/medicine/news/rituximab-podcast/embed/#?secret=PeRF1DtEy3" width="600" height="338" title="&#x201C;Dr. Patrick Nachman Answers Common Questions about Rituximab Treatment in New Chair&#x2019;s Corner Podcast&#x201D; &#x2014; Department of Medicine" data-secret="PeRF1DtEy3" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><thumbnail_url>https://www.med.unc.edu/medicine/wp-content/uploads/sites/945/2018/12/rituximab-podcast-image2.png</thumbnail_url><thumbnail_width>320</thumbnail_width><thumbnail_height>400</thumbnail_height><description>What should patients know about treatment with rituximab for ANCA vasculitis? What do physicians consider when starting a patient on this medication? Dr. Patrick Nachman and Dr. Ron Falk explain these details in a new episode of Chair's Corner. Dr. Patrick Nachman is the Covington Distinguished Professor of Medicine in the Division of Nephrology and Hypertension at UNC, and he also serves as the Deputy Director for the UNC Kidney Center.</description></oembed>
